TrialUnited European gastroenterology journal2024

Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial.

Alexey Surov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.